New articles and videos available!

New clinical studies have started or are scheduled for vitiligo.

Positive results for the phase 3 clinical study of oral upadacitinib in vitiligo.

Numerous ongoing and future trials for diffuse vitiligo
(at least 5% of the face AND 5% of the body affected).